306 results
8-K
EX-10.1
ENZ
Enzo Biochem, Inc.
24 May 24
Departure of Directors or Certain Officers
4:44pm
truthful statement to the extent necessary with respect to any litigation, arbitration, or mediation involving this Agreement, including, but not limited … . The Executive shall cooperate with the Company and its counsel in connection with any litigation or regulatory or self-regulatory inquiry
8-K
EX-99.1
ENZ
Enzo Biochem, Inc.
13 Mar 24
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
4:31pm
for the Company’s products, cost of goods sold, other expenses, government regulations, litigation, and general business conditions. See Risk Factors
8-K
EX-99.1
ENZ
Enzo Biochem, Inc.
1 Feb 24
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
8:33am
expenses, government regulations, litigation, and general business conditions. See Risk Factors in the Company’s Form 10-K for the fiscal year ended July
8-K
EX-99.1
lmiahwv
6 Sep 23
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
6:12pm
8-K
EX-99.1
0ajmg0w
24 Jul 23
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
4:32pm
424B3
xf0p9eeb wg
18 Jul 23
Prospectus supplement
9:42pm
424B3
98iobk9npt1q
21 Jun 23
Prospectus supplement
8:44pm
8-K
v1br 2gez
30 May 23
Other Events
4:15pm
8-K
EX-4.1
i7hiv5ljwfvz w6s
22 May 23
Entry into a Material Definitive Agreement
6:32am